Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to retinalgenix.com
RetinalGenix Technologies Inc. IR Overview
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
  • Stock Data
    • Quote & Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • At-a-Glance
    • Board of Directors
    • Governance Documents
  • chevron_leftBack to retinalgenix.com

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 5, 2025 6:15 am EDT
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
Mar 6, 2025 6:00 am EST
RetinalGenix Technologies to Participate at the 37th Annual Roth Conference
Feb 20, 2025 6:30 am EST
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Feb 22, 2024 6:05 am EST
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
Dec 26, 2023 12:45 pm EST
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
Dec 21, 2023 5:50 am EST
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
Dec 4, 2023 2:45 pm EST
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
Dec 1, 2023 12:32 pm EST
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
Nov 28, 2023 4:01 pm EST
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
Nov 9, 2023 12:58 pm EST
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
  • Page 1
  • Page 2
  • Page 3
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 RetinalGenix Technologies Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap